Junchen Hou
Overview
Explore the profile of Junchen Hou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
HJURP indicates poor prognosis of female breast cancer by promoting cell proliferation and migration
Chen W, Li H, Wang D, Yang S, Hou J, Zhou H, et al.
Genes Dis
. 2024 Aug;
11(6):101176.
PMID: 39139392
No abstract available.
2.
Chen X, Zhang H, Fang Z, Wang D, Song Y, Zhang Q, et al.
Cancer Cell Int
. 2024 Aug;
24(1):284.
PMID: 39135158
Background: Obesity and the forkhead box O1(FOXO1) affect the survival of breast cancer patients, but the underlying mechanism remains unclear. We aimed to investigate the role of FOXO1 in obesity-associated-breast...
3.
Sun X, Hou J, Ni T, Xu Z, Yan W, Kong L, et al.
Int Immunopharmacol
. 2024 Mar;
131:111803.
PMID: 38460298
Plasma cell mastitis (PCM) is a sterile inflammatory condition primarily characterized by periductal inflammation and ductal ectasia. Currently, there is a lack of non-invasive or minimally invasive treatment option other...
4.
Zhong Z, Hou J, Yao Z, Dong L, Liu F, Yue J, et al.
Nat Commun
. 2024 Mar;
15(1):1929.
PMID: 38431724
Single-cell and spatial transcriptome sequencing, two recently optimized transcriptome sequencing methods, are increasingly used to study cancer and related diseases. Cell annotation, particularly for malignant cell annotation, is essential and...
5.
Wang D, Zhang J, Jiang L, Chen X, Yang S, Hou J, et al.
Am J Transl Res
. 2023 Jan;
14(12):8788-8792.
PMID: 36628238
Background: Malignant adenomyoepithelioma (MAME) of the breast is an extremely rare breast malignancy, in which they arise from either luminal epithelial or myoepithelial components, or both. At present, there is...
6.
Chen X, Xu D, Li X, Zhang J, Xu W, Hou J, et al.
J Cancer
. 2019 Nov;
10(26):6608-6617.
PMID: 31777590
Endocrine resistance in hormone receptor positive breast cancer patients urges us to develop novel approaches such as inhibitors of the cyclin-dependent kinases (CDK) 4/6 to reverse its resistance. Nowadays, three...
7.
He Y, Deng F, Zhao S, Zhong S, Zhao J, Wang D, et al.
Epigenomics
. 2019 Jun;
11(9):1021-1036.
PMID: 31184216
Aerobic glycolysis is characteristic of breast cancer. Comprehensive expression profiles of key proteins, their prognosis and detailed relationships between miRNAs and mRNAs remain unclear. Oncomine database, Kaplan-Meier overall survival and...
8.
Zhong S, Wang J, Hou J, Zhang Q, Xu H, Hu J, et al.
Epigenomics
. 2018 Sep;
10(10):1301-1313.
PMID: 30215537
Aim: We aimed to explore the roles of circRNAs in gastric cancer. Materials & Methods: The dysregulated circRNAs and miRNAs were identified using data from Gene Expression Omnibus. The roles...
9.
Yu X, Zhou S, Wang J, Zhang Q, Hou J, Zhu L, et al.
Breast Cancer
. 2017 Jun;
24(5):643-657.
PMID: 28601917
Previous studies on the association between hormone replacement therapy (HRT) and breast cancer survival have yielded mixed results. We aimed to perform a meta-analysis to assess the association with all...